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Atherosclerosis leads to cardiovascular disease, which is the greatest cause of the death 
in the US. Atherosclerosis begins with endothelial dysfunction, including reduced nitric 
oxide production and subsequent vascular smooth muscle cell relaxation. Current methods 
to measure endothelial dysfunction are complex, low-throughput, and often require tissue 
harvested from animals, which limits human translation. 
Here, we present the foundation for a contractile artery-on-a-chip to investigate 
endothelial dysfunction. This device is comprised of a hydrogel channel in which human 
endothelial cells can be seeded together with circumferentially aligned vascular smooth 
muscle cells. In this thesis, I present data showing that the hydrogel channel can be made 
from a 1:1 collagen/GelMa  blend and withstand 20µL/min flowrate. I also present a 
method to circumferentially align vascular smooth muscle cells inside a channel on feature 
sizes as large as 0.35mm. Together, these components bring us closer to realizing an in 
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1.1 Clinical Relevance: Cardiovascular Disease and Atherosclerosis 
Cardiovascular disease (CVD) is the leading cause of death in the United States. The 
American Heart Association (AHA) reported in their 2020 Heart Disease Stroke Statistics 
update that more than 850,000 CVD-related deaths were recorded in 2017. CVD also has 
a profound financial impact. The same AHA report estimated that over $350 billion was 
spent on CVD from 2014 to 2015. This total includes both direct costs, such as hospital 
inpatient stays as well as emergency department visits, and indirect costs, such as lost 
productivity. These statistics are reflected globally, with CVD being the leading cause of 
death worldwide as well. CVD-related deaths are expected to reach over 20 million per 
year by 2030 [1]. 
CVD is an umbrella term for many conditions that affect the heart and/or blood vessels 
[2], most of which relate to atherosclerosis [3]. Atherosclerosis is characterized by lipid 
buildup in the arterial wall, eventually leading to atherosclerotic plaque formation [4]. The 
disease begins with endothelial dysfunction, which in turn enables lipids to permeate into 
the vessel wall. Leukocytes are also able to transmigrate through the disrupted 
endothelium. Some of these leukocytes differentiate into foam cells; lipid-laden 
macrophages that further plaque progression by producing proinflammatory cytokines [5]. 
In addition, smooth muscle cells proliferate and migrate into the atherosclerotic plaque. 
Indeed, vascular smooth muscle cells comprise the majority of foam cells [6]. In the latest 
stage, extracellular matrix (ECM) degradation destabilizes the plaque. As these plaques 
become increasingly unstable, they can eventually rupture, forming blood clots that 






1.2 Arterial Structure and Function in Health and Disease 
Arteries are made up of three tunica or layers: the outermost adventitia, consisting of 
connective tissue, blood vessels, and nerves; the middle tunica media, consisting of elastin 
fibers and smooth muscle cells; and the innermost tunica intima, consisting of a single layer 
of endothelial cells (ECs) attached to a basement membrane [7] as well as occasional 
vascular smooth muscle cells.  Arterial structure differs depending on the local vessel 
requirements. 
The three main types of arteries are elastic arteries, muscular arteries, and arterioles 
[8]. Elastic arteries, including the aorta, tend to be larger in diameter (>10mm) and have 
thick media layers. The larger vessel diameter and elastin-rich media layer allows these 
vessels to stretch in systole and snap back in diastole, reducing blood pulsatility. 
Conversely, muscular arteries, such as the femoral artery, tend to be smaller in diameter 
(10-0.1mm) and have relatively thinner media composed mostly of smooth muscle cells 
with little to no elastin fibers present [9]. These smooth muscle cells help muscular arteries 
vasoconstrict to control blood distribution throughout the body. Arterioles are small 
(<0.3mm) arteries that connect to capillaries. They are also known as resistance vessels for 
their role in resisting blood flow and thus decreasing blood pressure before the blood enters 
the capillaries. The capillaries are thin walled vessels, consisting of endothelium only, 
which allows efficient exchange of nutrients and waste between tissue and blood. 
1.2.1 The Endothelium 
The endothelium is the single layer of endothelial cells that line the vasculature. It 
serves many functions, such as wound healing and angiogenesis. It also maintains vascular 
tone, balancing vasodilation and vasoconstriction to regulate blood perfusion [10]. 
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Endothelial vasodilation is driven in part by nitric oxide (NO) while vasoconstriction is 
driven by endothelin and vasoconstrictor prostanoids [11]. NO is of special importance, as 
dysfunctional NO production is an effective marker of overall endothelial dysfunction [12]. 
1.2.2 Normal Endothelial Cell Function: Shear Stress Response and NO Production 
ECs form a continuous monolayer to line the entire vascular system, including arteries, 
capillaries, and veins [13]. As a result, these cells are in direct contact with blood and other 
molecules found in the bloodstream, as well as the vascular wall. This allows the 
endothelium to communicate hemodynamic changes into the surrounding tissue [14]. 
These hemodynamic changes, such as increased shear stress, cause endothelial cells to 
align and elongate in the flow direction and evoke cardioprotective responses such as NO 
production in the healthy endothelium. Endothelial cells sense shear stress through several 
different mechanosensors, including integrins, the glycocalyx [15], ion channels [16], 
intercellular junction proteins such as PECAM-1 [17], and even the actin cytoskeleton itself 
[18].  
Endothelial NO production is a gold-standard measure of endothelial health. NO dilates 
blood vessels and protects the endothelium by inhibiting platelet and leukocyte adhesion 
[19]. NO also acts as an anti-inflammatory agent and antioxidant [20]. Endothelial nitric 
oxide synthase (eNOS) is the primary NO producing enzyme in the endothelium. The 
enzyme is dimeric and contains two domains which bind NADPH, flavin mononucleotide, 
flavin adenine dinucleotide, tetrahydrobiopterin (BH4), oxygen, and L-arginine [21]. 
NADPH, molecular oxygen, and L-arginine are the primary substrates for NO production 
while the flavins and BH4 serve as cofactors. One of the domains also contains a calmodulin 
binding sequence that, once bound, initiates the NO production process [22]. Electrons 
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from NADPH are passed between the eNOS domains to reduce molecular oxygen, which 
combines with L-arginine to ultimately produce NO and L-citrulline [21]. Despite its 
normal protective function in producing NO, eNOS  may also contribute to CVD since it 
can produce reactive oxygen species in its uncoupled form [23]. 
1.2.3 Endothelial Dysfunction in Atherosclerosis 
Endothelial dysfunction initiates atherosclerotic plaque formation [22, 23] and can be 
caused by several factors. Disturbed blood flow is well established to promote endothelial 
dysfunction and is supported by preferential atherosclerotic plaque formation at vessel 
bifurcations, where flow would be disturbed compared to straight vessel sections where 
flow is more unidirectional [26]. This disturbed flow is characterized by lower resulting 
shear stress on the endothelium and by areas of recirculation. Through 
mechanotransduction, reduced shear stress from disturbed flow activates proatherogenic 
effects in ECs. Many of these effects relate to the inverse of the atheroprotective EC effects 
previously mentioned. Proatherogenic ECs are proinflammatory, promote 
vasoconstriction, and produce reactive oxygen species [24]. As mentioned before, these 
ECs also have decreased NO bioavailability. These effects together promote atherosclerotic 
plaque development. 
1.2.4 Vascular Smooth Muscle Cells 
Vascular smooth muscle cells (SMCs) actively contract and relax to constrict and dilate 
the vessel, respectively. As with all smooth muscle cells, their activity is involuntarily and 
is instead controlled by regulating molecules in the bloodstream and produced by the 
neighboring ECs. NO is one such vasodilation regulating molecule. To successfully carry 
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out their function, SMCs assume a particular orientation. Specifically, they are 
circumferentially aligned about the vessel lumen, forming a ring-like structure [27]. 
1.2.5 Normal Function of SMCs: Contractile Machinery 
SMC contraction can be initiated by mechanical, hormonal, or neural stimuli [28]. 
Regardless of stimulus type, the initiating contractile event is an influx of Ca2+ [29]. Ca2+ 
may come from outside the cell or from the Ca2+ stores in the sarcoplasmic reticulum. Ca2+ 
binds to calmodulin in a 4:1 ratio causing a conformational change in calmodulin. This 
conformational change allows myosin light chain kinase (MLCK) to also bind, forming a 
Ca2+-calmodulin-MLCK complex which activates MLCK and phosphorylates one of the 
two light chains of myosin. Phosphorylated myosin forms cross bridges with cytoskeletal 
actin and produces the forces necessary in contraction. 
SMC relaxation is initiated either indirectly by removal of the contractile stimuli or 
directly by a vasodilator, such as NO. Intracellular Ca2+ levels are decreased, either by 
complete removal from the cell or by Ca2+ sequestration in the sarcoplasmic reticulum [30]. 
Additionally, relaxation requires increased myosin light chain phosphatase (MLCP) 
activity, which returns myosin to its inactive state. 
1.2.6 SMC Dysfunction in Atherosclerosis 
Similar to ECs and the endothelium, SMCs also become dysfunctional in disease. In 
early atherosclerosis, specifically the pathological intima thickening stage, SMCs present 
decreased alpha smooth muscle actin (αSMA) expression. αSMA plays an integral role in 
contraction as described previously [31]. This is the first indication SMC phenotype 
switching away from the healthy contractile phenotype and towards the pathological 
proliferative/synthetic phenotype. SMCs in this stage of atherosclerosis also present 
7 
 
increased apoptosis [32] and expression of chemokines that recruit monocytes [33]. In later 
atherosclerosis, SMCs show more extensive phenotypic switching, resembling foam cells 
[34] and macrophages [35], which further progress the atherosclerotic disease state. 
SMC phenotype change also occurs during cell culture, hindering in vitro SMC study. 
During cell culture, expression of contractile marker proteins, such as smooth muscle 
myosin heavy chain (MHC) and smoothelin, are decreased [36]. This may be caused in 
part by the traditional cell culture process in which cells are encouraged to proliferate by 
media supplemented with growth factors. Thus, a major challenge for in vitro SMC studies 




1.3 Current Methods to Study Endothelial and Smooth Muscle Dysfunction 
As described previously, endothelial dysfunction is an important marker of poor 
vascular health and an initiator of atherosclerosis. Therefore, methods to quantify 
endothelial dysfunction would be helpful in studying disease development and progression. 
Several methods are currently available to measure endothelial dysfunction. 
1.3.1 NO Measurements 
Measuring NO is arguably the most straightforward method of determining endothelial 
dysfunction but presents several challenges since NO is inherently unstable and has a short 
half-life [37]. Despite this challenge, NO has been measured in humans using a 
electrochemical microsensor [38]. However, these experiments suffered many issues 
including fragile equipment, which means that gathering large amounts of reproducible 
data in this fashion is not a feasible approach. 
Current techniques for directly measuring NO still use electrochemical electrodes. 
Amperometry is class of techniques to measure relevant NO levels in vitro and in vivo [39]. 
In amperometry, a voltage is applied between two electrodes in steel sleeves. The sleeve 
tip is covered with an NO-selective membrane. NO from the sample diffuses through the 
membrane and is oxidized. The amount of oxidation is measured by the current between 
the two electrodes. More modern amperometric approaches use NO-scavenging 
membranes instead of NO-selective membranes, improving measurement specificity [40]. 
However, these electrochemical, electrode-based methods also have some disadvantages. 
As with most probe-based assays, the probe position can drastically affect results. 
Furthermore, at the picoamp measurement scale, electrical noise can muddy the acquired 
signal, even with Faraday-shielded probes. Indirect approaches of probing for NO 
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molecules have also been developed. These techniques measure either a byproduct of NO 
production or a resultant effect of NO bioavailability. For example, NO production can be 
estimated by measuring eNOS activity. Radioactively-labelled L-arginine is converted to 
L-citrulline by eNOS during NO production, which can be readily quantified [41]. Nitrate 
is another byproduct of NO and has also been used to indirectly measure NO [42]. 
However, this approach is less specific than the citrulline assay [43]. Finally, NO 
production can be measured via fluorescent probes such as DAF-FM diacetate, which 
permeates the cell membrane and fluoresces after reacting with NO [43]. 
1.3.2 Flow-mediated Vasodilation 
Flow-mediated vasodilation (FMV) is an arterial response in which the vessel dilates 
as a result of increased blood flow [44]. This increase in blood flow increases shear stress, 
inducing NO production, thus leading to vasodilation. In FMV to study arterial function, 
B-mode ultrasound is used to visualize the diameter of a large surface vessel, often the 
brachial or femoral artery. The vessel diameter is then measured in three conditions: 
baseline, during hyperemia induced by a blood pressure cuff, and after stimulation of NO 
production enhancers such as bradykinin. This compares the endothelium at rest, during 
endothelium-dependent vasodilation, and during endothelium-independent vasodilation, 
respectively [45]. In these experiements, dilation by increased shear stress has been 
reported to be on the order of 10% compared to baseline [46]. 
FMV based assays are appealing as they are non-invasive and can be used with human 
subjects, but they offer very low throughput and require specialized training to perform 
and analyze. In addition, the reliance on ultrasound limits FMV based assays to larger 
surface vessels, precluding the study of resistance vessels. 
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1.3.3 Wire and Pressure Myography 
Myography is a class of techniques to measure vessel function using harvested vessel 
samples  [47]. In wire myography, resistance vessels are harvested, and two fine wires are 
threaded through the vessel. One wire is anchored to a micrometer while the other is 
anchored to a force transducer. As the vessel contracts and relaxes the transducer quantifies 
the force data [47]. 
Pressure myography is similar to wire myography with a slightly different setup. 
Instead of threading wires through the vessel, the sample is loaded onto two cannulae such 
that flow can be directed through the vessel. This vessel-cannula setup is kept inside a small 
chamber, similar to wire myography, but with the added functionality of allowing an 
outside flow to be run at the same time as the vessel flow. Both flows can be controlled, 
and the flow solutions can be treated and conditioned with molecules and proteins of 
interest. A camera is used to measure changes in vessel diameter, similarly to the 
methodology of FMV [48]. In pressure myography, high dosages of acetylcholine have 
been reported to constrict vessels up to 80% [49]. 
In both wire and pressure myography, a live vessel sample is required. Maintaining 
animal models is costly, and harvesting tissue samples poses ethical concerns. Harvesting 
and handling vessel samples also requires specialized training. Furthermore, results from 
animal models are not fully translatable to human physiology.  
1.3.4 Vessel-on-a-chip Devices 
Organ-on-a-chip systems are 3D in vitro cell culture platforms that recapitulate the in 
vivo cellular environment and stimuli [50]. This allows cells in culture to be significantly 
more representative compared to traditional 2D culture and circumvents the need for live 
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tissue harvesting. The organ-on-a-chip is specifically designed for the cells and organ of 
interest. In the case of vessel-on-a-chip devices, this involves designing a lumen-like 
channel structure on which ECs can be seeded and through which flow can be directed. 
This can be achieved through the use of sacrificial molds or soft lithography [51]. Other 
approaches circumvent the use of cells by harvesting vessel samples directly from animals 
[52]. Yasotharan et al. developed a microfluidic device in which small artery samples could 
be loaded and directly observed during vasodilation and vasoconstriction [53]. As 
convincing as these data are, this approach requires invasively harvesting tissue from 
animals. Thus this approach is not as relevant to human disease since human cells are not 
used and is throughput limited similarly to myography as harvested tissue samples are 
required. 
Vessel-on-a-chip devices are advantageous in that they can be used to achieve results 
comparable to that of native vessels without the related costs of maintaining animals or 
waiting on sample donors. As they can be produced as needed, throughput is improved 
compared to other methods. Furthermore, human cells can be used, opening possibilities 
for personalized assays and pharmacological development. However, as with all previously 
described methods, vessel-on-a-chip devices also have inherent disadvantages. As they are 
manually fabricated, certain methodologies invite opportunities for variability among 
devices. This also increases the difficulty in reproducing these devices by peers. Despite 
these disadvantages, vessel-on-a-chip devices are powerful tools that can be customized 
for specialized test conditions. 
Many current vessel-on-a-chip devices feature human ECs in their design. These ECs 
are sometimes seeded on substrates that are relatively rigid compared to the adventitia, 
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such as polydimethylsiloxane, while other approaches seed cells on hydrogels that are more 
mechanically and biologically representative of the native anatomy. However, as of yet, no 
vessel-on-a-chip device has been created with human ECs and SMCs integrated in such a 
way that the vessel can contract and relax to an appreciable, visually observable degree. 
The ability to vasoconstrict and vasorelax fundamentally distinguishes this artery-on-a-




1.4 Directed Cell Alignment In 2D and 3D 
In vivo, ECs and SMCs are specifically aligned to facilitate their particular function. 
ECs are aligned in the blood flow direction [13], and SMCs are aligned circumferentially 
about the vessel (referred to as “3D alignment”) [27]. Therefore, to create a representative 
vessel-on-a-chip device, these alignments must be recreated. In 2D (flat) systems, this has 
been accomplished through several means, including topographical features [54], electrical 
stimulation [55], and mechanical forces [56]. 3D cell alignment has been less studied but 
will be integral in the vessel-on-a-chip to be developed here. 
1.4.1 Topographical Features 
A common approach to directed, in vitro cell alignment is to seed them on surfaces that 
contain physical, micro- or nano-scale alignment features. This can be as simple as a micro-
ridge pattern, which has been demonstrated to effectively align ECs [54]. Briefly, silicone 
groove and ridge features of various dimensions (400-4000nm pitch) were fabricated using 
x-ray lithography and used as master molds to pattern polydimethylsiloxane stamps. An 
optical adhesive that cures to a rigid polymer upon exposure to UV light was spin coated 
in tissue culture plates to form a flat layer. The PDMS stamps were pressed into this 
adhesive layer prior to UV exposure and then were removed. This formed ridged alignment 
patterns in the tissue culture plates. ECs seeded on these topographic patterns began to 
align in the direction of the grooves and ridges in as little as 30 minutes, with longer 
adherence time increasing the degree of alignment.  
SMCs have also been aligned using topographical methods [57]. Instead of a flat, 
patterned surface, SMCs were seeded on synthetic elastin (SE) fibers aligned by 
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electrospinning. Compared to cells seeded on a glass control group and cells seeded on 
randomly arranged SE fibers, SMCs seeded on the aligned SE fibers were greatly aligned. 
1.4.2 Electrical Stimulation 
Electrical fields have also been demonstrated to effectively align ECs [55]. Both the 
electrical field intensity as well as the exposure duration affect EC alignment. Higher 
voltages (>75mV/mm) and longer durations (>4 hours) tend to align cells to a greater 
degree. Electrical stimulation is known to induce vascular endothelial growth factor 
receptor (VEGFR) activation [58], and so VEGFR was hypothesized as the mechanism 
underlying EC reorientation. This hypothesis was confirmed by increased VEGFR levels 
in the cell culture media of electrically stimulated cells compared to unstimulated cells. 
Also, chemical inhibition of VEGFR resulted in total loss of cell alignment behavior even 
under electrical stimulation [55]. This hypothesis was further explored, and it was 
discovered that downstream of VEGFR activation, phosphatidylinositol-3-kinase (PI3K)-
Akt and Rho-ROCK activation are major pathways that result in EC reorientation. 
1.4.3 Mechanical Forces 
Mechanical forces can also be applied to align cells in vitro. As described previously, 
ECs align when subject to physiological shear stress and can be aligned in vitro using this 
approach. A parallel plate flow chamber was specifically designed to allow concurrent 
traction microscopy to elucidate this cellular response [59]. Briefly, it was discovered that 
the initial response to shear stress from laminar flow is a rapid decrease in intercellular 
stresses which is followed by slower alignment of the EC body. While these types of 
stimuli are naturually present, their application to SMCs is not as relevant as their 
application to ECs. In addition, engineering these types of forces consistently in vitro poses 
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a greater technical challenge than consistently creating alignment features for 
topographical alignment. 
1.4.4 Cell Alignment Methods in 3D 
While aligning cells in 2D, that is, on a flat surface, has been well documented with 
various approaches, directing cell alignment in 3D is a significantly greater challenge. 
Many approaches are related to tissue engineering practices involving scaffold fabrication 
[60]. For example, SMCs alignment in 3D was achieved using a novel layer-by-layer 
seeding method. Briefly, a thin (60 µm) film microchannel scaffold was fabricated using a 
topographically patterned polydimethylsiloxane mold in a process similar to the EC 
topographical alignment method described previously. SMCs were seeded onto this 
scaffold and maintained until confluent and aligned. A that point, a thin hydrogel layer was 
deposited on the cell monolayer. A second thin film microchannel scaffold was fabricated 
on top of this hydrogel layer, and a new cell layer was seeded as before. This process was 
repeated until a 3D structure of aligned SMCs was achieved. In theory, the microchannel 
structure could be modified to create different alignment patterns, but this has not yet been 
explored. While this approach is straightforward and does indeed achieve 3D alignment of 




1.5 Thesis Overview 
In this thesis, several important steps were taken in the process of creating an artery-
on-a-chip for pressure myography using human ECs and SMCs. Specifically, a more stable 
channel was created in a collagen - gelatin-methacryloyl (GelMa) blend hydrogel to enable 
longer term culture of the artery-on-a-chip; and second, a new technique was developed to 
circumferentially align SMCs inside the channel.  
Aim 1: Collagen/GelMa Channel Formation & Endothelial Cell Adhesion 
Prior attempts to create a channel within a collagen hydrogel for the artery-on-a-chip 
were unreliable and unstable. We therefore decided to use a collagen/GelMa blend for the 
hydrogel channel. Different concentrations of collagen, GelMa, and photoinitiator were 
tested to determine which combination would create a stable channel on which ECs could 
be seeded to form a vessel lumen-like structure.  
Aim 2: Topographical Circumferential Alignment of Vascular Smooth Muscle Cells 
Although quite effective and straightforward in 2D, topographical alignment can be 
difficult in 3D. We therefore developed a novel technique in which the ridges created 
during 3D printing are used to create topographical features in the collagen/GelMa 
hydrogel. We tested the technique on flat surfaces, curved surfaces, and inside a channel.  
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2. Collagen/GelMa Hydrogel Channel Formation & Endothelial Cell Adhesion 
2.1 Introduction 
Hydrophilic gels, more commonly referred to as “hydrogels,” are large 3D polymer 
networks of crosslinked hydrophilic chains [61]. In practice, hydrogels can be formed 
through a variety of methods. Some involve neutralization of the dissolved polymer 
solution which induces auto-assembly. Others require crosslinking neutral polymers 
dissolved in water with a crosslinking agent activated by an external energy source such as 
ultraviolet (UV) light [62]. Regardless of the polymerization method, the tunable, 
hydrophilic, and biocompatible nature of hydrogels make them a favorable biomaterial for 
biomedical research. As such, hydrogels are used in many different areas of biomedical 
research, including tissue engineering [63], drug delivery [64], and even wound healing 
[65]. In this chapter, we use channels formed in collagen- and gelatin-based hydrogels as 
the foundation for the artery-on-a-chip device. 
Our hydrogel channel fabrication process is based on a design created by Peter Galie 
[66]. Briefly, Galie’s design consists of a chamber formed between two 
polydimethylsiloxane (PDMS) slabs. The chamber is then filled with a prepared collagen 
solution. Two thin needles are inserted into the chamber, after which the collagen solution 
is exposed to the proper temperature (37°) to form a hydrogel. The needles are then 
removed, resulting in two parallel micro-channels. These channels are then seeded with 
cells and subjected to flow. In our experiments, this method sometimes produced a viable 
channel, but more often than not the channel collapsed either prior to or after the application 
of flow. This was due to several factors. First the channel diameter in Galie’s design was 
significantly smaller than the channel diameter required for our purposes. In addition, the 
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gel composition in Galie’s design could withstand flow to their specifications (2.4µL/min) 
but could not maintain structural integrity at higher flow rates. Thus, a new hydrogel was 
needed to increase channel stability. 
I modified the gel composition by adding a gelatin methacryloyl (GelMa) component 
to create a more stable hydrogel for cell seeding and flow experiments. GelMa is a UV 
crosslinkable hydrogel composed of gelatin and methacrylic anhydride. Gelatin is 
hydrophilic polymer produced by hydrolizing collagen [67]. Methacrylic anhydride is a 
liquid that when reacted with certain organic compounds leads to the attachment of 
methacryloyl side groups, hence the name “gelatin methacryloyl.” When dissolved in water 
and in the presence of a photoinitiator, GelMa can be readily crosslinked with exposure to 
UV light [68]. The main benefit of GelMa is its improved mechanical stability and 
adherence to PDMS compared to collagen hydrogels. Outside of organ-on-a-chip systems, 
GelMa has also been used to encapsulate cells [69], as scaffolds for load-bearing tissue 





2.2.1 PDMS Device Fabrication 
Device fabrication began with polymerization of a PDMS top. The PDMS was prepared 
with a standard 10:1 ratio of elastomer base and curing agent, respectively, which was 
thoroughly mixed by hand with a tongue depressor. 11g of PDMS prepared in this way was 
then poured into the lid of a 100 mm culture dish. The PDMS was degassed using a 
desiccator for at least 30 minutes to remove air bubbles created during the mixing. After 
the PDMS was free of air bubbles, the culture dish lid was placed in an 80°C oven overnight 
to complete the curing process. 
Once the PDMS top was completely cured, a second batch of PDMS was prepared and 
degassed as above. A thin layer of wet PDMS was poured on top of the cured PDMS top 
in the culture dish lid. Then, the remaining wet PDMS was poured over eight previously 
fabricated positive molds of the final device design. The PDMS coated molds were then 
inverted onto the wet PDMS in the culture dish lid, and the PDMS was degassed again to 
remove any remaining air bubbles. This PDMS layer is hereafter referred to as the “device” 
layer. After 30 minutes of degassing, any air bubbles that remained were removed by hand 
using sharp-pointed forceps. At this point the culture dish lid was again placed in the 80°C 
oven for at least 20 but not longer than 30 minutes.  
Once the device layer had solidified, the culture dish lid was removed from the oven. 
The entire PDMS top and device layers, which were now fused, was removed from the lid. 
The molds were carefully removed from the PDMS, leaving an open chamber and inlet 
ports. The PDMS was cut into eight individual devices and all devices were plasma treated 
(Harrick, PDC-001) along with eight 20x40mm rectangular coverslips (VWR, 48382-126) 
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on high for 1 minute. The inlet ports were then created with a 1mm biopsy punch (Miltex, 
33-31AA-P/25). 
A PDMS base was prepared in a 100 mm culture dish lid as described for the first slab. 
This base was cured until just barely solid, which occurred after approximately eight 
minutes in the 80°C oven. The eight separate PDMS device layers were inverted onto the 
PDMS base. The eight PDMS device layers were then cured with the PDMS base in the 
80°C oven for at least 30 more minutes. The devices were then cut into eight individual, 
complete PDMS microfluidic devices. Each device was placed onto a coverslip and all 
devices were kept in the 80°C oven overnight to complete the curing process (Figure 2.1).  
  
Figure 2.1: PDMS molding process for forming microfluidic device. (a) Wet PDMS was cured in a cell 
culture dish lid to form the PDMS top. (b) The PDMS molds were inverted onto a layer of wet PDMS 
on the cured PDMS top. (c) The PDMS molds were removed, leaving an open-faced device layer. (d) 
After plasma treating the device layer and glass coverslip, the cured PDMS top was bonded to a freshly 
cured PDMS base. 
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2.2.2 Collagen Hydrogel Gelation 
PDMS devices were first coated with a thin layer of collagen to improve hydrogel 
attachment to the PDMS device and maintain structural integrity during flow. To prevent 
the uptake of small molecules [71], each device was treated with 200 µL of 5 M sulfuric 
acid for 90 minutes. The devices were washed 10 times with 1X phosphate-buffered saline 
(PBS, Gibco) prior to loading 10-50µg/mL Type-1 rat-tail collagen solution Gibco, 
A1048301), which was enough to fill the entire central chamber but not the inlet ports. The 
devices were then placed in a 37°C cell incubator for 1 to 3 hours to allow the collagen to 
adhere to the PDMS. After the collagen coating, the devices were again washed with PBS 
and kept in a 4°C refrigerator until use. 
 The collagen hydrogel solution was then prepared. All steps were performed in a 
biosafety cabinet to maintain sterility. Prior to beginning, deionized (DI) water, 10X PBS, 
1M NaOH, 2 mL centrifuge tubes and collagen solution (either manually dissolved in 
acetic acid from a lyophilized solid (MP Biomedical, 150026) or pre-dissolved (Advanced 
Biomatrix, 5226) was placed on ice for 30 minutes to prevent premature collagen gelation 
during the hydrogel fabrication process. Then, 100 µL 10X PBS, 90 µL DI water, and 10 
µL 1M NaOH were sequentially added to a 2 mL centrifuge tube and thoroughly vortexed. 
After mixing, 800 µL of collagen solution was added to the centrifuge tube to create an 
approximate final volume of 1000 µL. Solution pH was tested by pipetting a small volume 
of collagen solution onto a pH strip. 0.1 M NaOH was used to adjust the solution pH to 7. 
22 
 
Once the gel solution was prepared, the PDMS devices were retrieved from the 
refrigerator and kept on ice along with the gel solution. Needles ranging in diameter from 
100 µm to 600 µm were dipped in 1X PBS and then inserted through the devices as shown 
in Figure 2.2. Up to 200µL of gel solution was injected into the device using a corner inlet 
port, and the devices were incubated 
again at 37°C for 1 to 24 hours to 
complete collagen gelation. If cells were 
not immediately seeded after gelation, 
devices were stored in a 4°C refrigerator 
until cell seeding. 
The needle diameter ultimately determines the channel diameter. Resistance vessels in 
the body fall under 400µm diameters [72] which can be achieved by using smaller needles. 
2.2.3 Gelatin Methacryloyl (GelMa) Synthesis 
Gelatin methacryloyl (GelMa) was synthesized as an alternative to collagen hydrogels. 
Gelatin was first reacted with methacryloyl over 1 to 2 hours by dropwise addition of 
methacrylic anhydride (MA, Sigma Aldrich 276685) to Type A gelatin (G2500-500G, 
Sigma Aldrich). For 30 mL of 10% w/v gelatin in PBS, 2.3 mL of MA was added via 
syringe pump (New Era Pump Systems Inc., NE-1000) set at a flow rate of 20 µL/min. 
Solution temperature was maintained between 45°C and 50°C to prevent gelatin 
denaturation. The solution was vigorously stirred with a magnetic stir bar at 1200 rpm.  
After the MA was fully added to the gelatin solution, the solution was transferred to a 
50 mL Falcon tube and centrifuged at 1000g for 2 minutes to pellet the unreacted MA. The 
supernatant was then collected and diluted 1:1 with PBS to create a 5% w/v gelatin solution. 
Figure 2.2: PDMS device with 0.5 mm diameter 
needle inserted prior to gel solution loading. 
Grid = 10mm. 
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This solution was then dialyzed in two 10kDa MW cutoff dialysis cassettes (Thermo 
Scientific 66830) submerged in DI water in a 50°C oven for two days to remove any 
unreacted MA. DI water was refreshed each day. 
The GelMa solution was then adjusted to pH 7-7.4 using 1 M NaOH. 35 mL of solution 
was then transferred to 50 mL Falcon tubes and frozen at -20°C for at least 30 minutes 
before further freezing at -80°C overnight. Once the solutions were completely frozen, all 
samples were lyophilized (Labconco, 700611000) for 5 days. The cotton-like white solid 
was stored in the dark at room temperature prior to use. 
2.2.4 GelMa Devices 
To create GelMa hydrogels within the previously described PDMS devices, solid 
GelMa was transferred into scintillation vials (Kimble, 74504-20) and UV sterilized for at 
least 30 minutes before dissolving in PBS for at least 30 more minutes at 37°C. 
Immediately before loading the GelMa solution, 20-60 µL of 5% lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) photoinitiator solution (Sigma Aldrich, 900889-1G) 
was added into the GelMa solution, and the scintillation vial was thoroughly mixed with a 
micropipette. Up to 200 µL of the GelMa-LAP solution was injected into each PDMS 
chamber prepared with needles as described previously. Several devices were collected 
into a 100 mm culture dish. The dish was sealed with Parafilm to prevent oxygen from 
inhibiting the crosslinking reaction. The GelMa was crosslinked with UV light (254 nm, 
Analytik Jena, 95-0230-01) for 3 to 10 minutes. The result was a solid, semi-translucent 
hydrogel inside the PDMS device. Devices were stored at 4°C until cell seeding. 
2.2.5 Collagen/GelMa Blend Devices 
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In the final version of the device, a blend of collagen and GelMa was used for the 
hydrogel. The GelMa was synthesized and prepared as described previously. While the 
GelMa was dissolving in the incubator, a collagen solution was prepared as described 
previously. Immediately after adding the LAP photoinitiator to the GelMa solution, the 
GelMa solution and collagen solution were combined in various ratios and mixed 
thoroughly prior to loading into the PDMS devices. The solutions were first gelled by UV 
crosslinking as described in the GelMa devices section and then incubated at 37°C for up 
to 24 hours. The devices were then kept at 4°C until cell seeding. 
2.2.6 HUVEC Culture 
Human umbilical vein endothelial cells (HUVECs, Lonza, C2519A) were cultured in 
100mm polystyrene dishes maintained with Endothelial Growth Media (EGM-2, Lonza, 
CC-4176). Media was replaced every other day, and cells were used between passages 3 
and 8. In some experiments, GFP-mitochondria labeled cells were used. Prior to each 
experiment, HUVEC were washed with sterile PBS and detached from the culture dish 
with 2 mL of trypsin-EDTA (Gibco, 25200056). Cells were collected and counted using a 
Countess automated cell counter (Thermo Fisher Scientific, AMQAX1000). Cells were 
then concentrated by centrifugation at 5000RPM for 5 minutes, followed by removal of the 
appropriate volume of media to reach a cell density of approximately 5M cells/mL. Cells 
were resuspended by mixing. 
During cell preparation, hydrogel-filled PDMS devices were kept at room temperature 
in the biosafety cabinet for at least 10 minutes. The needles were carefully twisted to 
separate them from the hydrogel and pulled out of the devices using forceps. Each channel 
was then loaded with 100 µL of EGM-2 and incubated at 37°C for at least one hour. 100µL 
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of the HUVEC solution was then loaded into each device such that approximately 500,000 
cells were loaded into the channel. Devices were returned to the incubator for at least 30 
minutes to allow cells to adhere to the channel. During that time, a second HUVEC 
suspension was prepared. 100 µL of the second HUVEC suspension was added to the 
channel, but the devices were inverted such that the second set of cells adhered to the 
opposite side of the channel. After 30 minutes, devices were returned to their initial 
orientation and covered with cell media. Devices were stored in the incubator for 24 hours 
to allow cells to spread in the channels. 
2.2.7 Subjecting Cells to Flow 
HUVECs within the channels were then subject to flow to induce alignment. Cell-
seeded devices were transferred to a new 100 mm polystyrene dish with holes created in 
the lid using a soldering iron. Sterile 30 mL Luer lock syringes (BD, 309650) were filled 
with EGM-2 and assembled into a syringe pump (New Era Pump Systems Inc., NE-1600). 
Tygon tubing with 0.05 inch inner diameter (Component Supply, TND80-050) was used 
to connect to syringes to the device inlet ports. The flow rate was set between 5 µL/min 
and 340 µL/min. Cells were exposed to flow for 24 to 48 hours in a 37°C incubator. 
2.2.8 Cell Fixation and Imaging  
To image cells within the hydrogel channels, the channels were washed with cold PBS 
and fixed with 4% paraformaldehyde (PFA, Invitrogen, FB002) for 15 minutes on ice. All 
solutions were loaded into the hydrogel channels using a micropipette and gel-loading tips. 
The channels were washed again with PBS for 5 minutes. 0.1% Triton X-100 (Alfa Aesar, 
A16046-AP) was used to permeabilize cells for 5 minutes, followed by two additional PBS 
washes for 5 minutes each. Cells were blocked with 1% bovine serum albumin (BSA, 
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Sigma Aldrich, A9418) for 30 minutes and then labeled with 0.05% Hoechst (Invitrogen, 
H3570) and 1.25% rhodamine phalloidin (Biotium, 00027) for nuclei and actin, 
respectively. A confocal laser scanning microscope (Nikon, Eclipse Ti2-E) was used to 
image the hydrogel channels. Images were obtained at 10x and 20x magnification using 
2.5 µm steps over a range of at least 500 µm to visualize the entire channel. 
2.3 Results 
2.3.1 PDMS Device 
The first step in creating the hydrogel device was improving the method for air bubble 
removal from the PDMS devices. Initially, air bubbles were removed with degassing in a 
desiccator only. Devices created using this technique had large amounts of air bubbles 
(Figure 2.3). While primarily a cosmetic issue, these bubbles prevented effective 
observation of the gelation process and in some devices, appeared to hinder gelation as 
well. Manually removing air bubbles using sharp forceps reduced the air bubbles; however, 
some small air bubbles still formed during the 20-30 minute cure (Figure 2.4). Increasing 
degassing time to a minimum of 30 minutes removed the remaining air trapped in the wet 
PDMS, preventing air bubbles from forming in the PDMS during the curing process. These 
changes resulted in PDMS devices with few to no air bubbles for improved structural 





Figure 2.3: Initial PDMS devices created with only degassing and no manual bubble 
removal had large air bubbles that obscured viewing the channel and may have hindered 
hydrogel gelation. Grid = 10 mm. 
Figure 2.4: Manually removing air bubbles using sharp forceps reduced the number of air 
bubbles; however, additional bubbles still formed during the curing process. Grid = 10 
mm.  
Figure 2.5: 30 minutes of degassing along with manual air bubble removal resulted in final PDMS 
devices with few air bubbles.  
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2.3.2 Collagen Hydrogel Gelation 
The next step in creating the hydrogel device was improving the collagen gel. Initially, 
the collagen solution was manually prepared by dissolving lyophilized bovine collagen in 
acetic acid at room temperature over a 24-hour period.  When collagen solutions prepared 
in this way were used, the collagen did not gel in most experiments (Figure 2.6).  Even 
when the collagen did gel, needle extraction often disturbed the gel completely with no 
evidence of channel formation. 
In these initial experiments, pH was measured using a pH meter (Fisher Scientific, 
AE150) equipped with a microprobe that fit inside a centrifuge tube. While the pH 
measurements acquired with this probe were more accurate and precise compared to those 
obtained with pH strips, the extended measurement time combined with the need to take 
several measurements led to premature collagen gelation. Using pH strips improved 
collagen gelation greatly by decreasing the time required to measure pH. Decreased 
measurement accuracy and precision was not a significant loss, as an approximate pH 
(~7.4) was sufficient for gelation. 
I therefore formed the next set of hydrogels by dissolving collagen at 4°C and 
measuring pH with pH strips. This protocol resulted in more stable gels; however, gel 
formation remained inconsistent. Deionized water colored with orange dye was used to 
visualize collagen channels. As in previous samples, many gels were still disturbed upon 
needle extraction (Figure 2.7). 
Final collagen devices were fabricated using commercially-available pre-dissolved 
collagen solution instead of manually dissolved collagen. While manually dissolving 
collagen is advantageous in that the collagen concentration can be controlled, it requires 
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careful pH titration which leads to variations in the final collagen concentration. 
Commercially-available pre-dissolved collagen facilitated more consistent pH and 
concentration control. Finally, rigid syringe needles instead of flexible acupuncture needles 
resulted in more stable channel formation, as the needle did not flex into the gel during 
removal (Figure 2.8).  
Although collagen devices fabricated using the improved protocols were more stable 
and reliable in forming channels, the collagen gels were still not consistently stable and 
often were disrupted during flow. I therefore explored GelMa hydrogels due to the simple 
gelation process and the ability to control hydrogel mechanical properties in different ways: 
by adjusting the gelatin concentration, photoinitiator concentration, or UV crosslinking 
time. For these devices, 5% w/v gelatin and 0.1% w/v photoinitiator was UV crosslinked 
for three minutes. Compared to collagen devices, GelMa devices displayed more consistent 
gel and channel stability. In addition, the resulting gel was almost completely transparent 
(Figure 2.9).  
  
Figure 2.6: Lyophilized bovine collagen dissolved in acetic acid at room temperature for 24 hours 




Figure 2.7: Collagen gels often became unstable within PDMS devices, as demonstrated using an orange dye to 
visualize the channels. Improved collagen procedures resulted in more stable gels (left), although many gels were 
still disturbed when needles were removed (right). Lyophilized collagen was dissolved at 4°C, and pH was measured 
with pH strips. Grid = 10mm 
Figure 2.8: Gels fabricated with pre-dissolved collagen gel instead of lyophilized collagen resulted in more 
stable gels, especially after needle removal.  
Figure 2.9: GelMa hydrogel devices were significantly more stable compared to collagen hydrogel devices 
and were more transparent. An orange dye was perfused through the GelMa channel with little resistance 
and no visible gel disruption. 
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2.3.3 Collagen/GelMa Blend Devices 
While the GelMa devices were stable, they formed jagged edges inside the channels 
during needle removal likely due to gel binding to the needle during UV crosslinking. 
These edges did not prevent cells from adhering to the channel but might have disturbed 
flow and prevented endothelial cell alignment in the flow direction. To create a stable gel 
with a smooth channel, a blend of collagen and GelMa was explored. Various ratios of 
collagen to GelMa were tested . The 1:1 collagen/GelMa blend created a stable gel with a 
smooth channel. When collagen was increased, the gels became less stable without a 
discernable a change in channel smoothness (Figure 2.10). I therefore decided to use a 1:1 
collagen/GelMa solution for the final hydrogel device. 
  
Figure 2.10: A 1:1 collagen/GelMa blend created a stable gel with a smooth channel. Collagen/GelMa blend 
devices made using different collagen GelMa ratios. (Top row) Gels prior to UV exposure. (Middle row) Gels 




2.3.4 HUVEC Seeding 
During development of each device type (collagen, GelMa, and collagen/GelMa 
blend), HUVECs were seeded into the devices when the channels appeared stable enough 
to support cell adherence. This seeding process also was improved over the course of the 
device development.  
In collagen gels formed using manually dissolved collagen at room temperature, GFP-
mitochondria labeled HUVECs were used to enable imaging immediately after cell seeding 
(Figure 2.11). In this way, I could ensure proper cell loading in the device and avoid 
damaging the unstable collagen gels by injecting cell fixation and labeling solutions. In 
these collagen gels, cells adhered to the collagen gel but did not exhibit expected spreading.  
Collagen devices fabricated with manually dissolved collagen at 4°C and pH balanced 
with pH strips were seeded with unlabeled cells, which were then fixed and labeled for 
nuclei and actin as described previously. Cells in these devices demonstrated expected 
spreading, but in many devices, the gel was still not mechanically stable and a lumen-like 
ring structure was not formed (Figure 2.12). In some experiments with these devices, the 
cell seeding process disrupted the collagen gels. This did not affect the adherence and 
spreading of cells, but in these cases, the cells adhered to the PDMS device rather than the 
collagen gel. 
When the pre-dissolved collagen solution was used, the first lumen-like ring structures 
were observed (Figure 2.13). Due to the large channel diameter, a lower magnification 
objective with a greater working distance was required to capture the entire channel. This 
resulted in lower confocal image quality, but enabled visualization of the clearly defined 
lumen-like ring structure when the z-stack was compressed as a maximum intensity 
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projection (MIP). However, the structure itself was not perfectly round. These imaging 
issues could be addressed by decreasing the working distance between the hydrogel 
channel and the microscope objective. Attempts were made to remove the bottom PDMS 
layer prior to imaging, but doing so caused significant damage to the hydrogel which had 
attached to the PDMS layer.  
Initial GelMa devices resulted in more rounded channels (Figure 2.14). These GelMa 
devices were also the first instance of an observable channel that ran the entire length of 
the device. Previous devices at most had short stretches of observable channels that were 
interrupted by a disturbance or failure in the gel. However, the previously described jagged 
edges formed during needle removal had a significant effect on cell adherence and 
orientation.  
1:1 collagen/GelMa blend devices also maintained a channel structure through the 
entire length of the device. With this specific gel formulation, smoother channel walls were 
observed compared to GelMa devices, but some major jagged features remained (Figure 
2.15).  
  
Figure 2.11: GFP-mitochondria labeled HUVECs adhered in the collagen channel but did not fully 
spread. Collagen solution manually dissolved at room temperature. Confocal microscopy, 10x 




Figure 2.12: HUVECs seeded in channels made from lyophilized collagen showed signs of 
spreading, but the overall channel structure was not present. The collagen solution was 
manually dissolved at 4°C. Cells were fixed with paraformaldehyde and labeled for nuclei 
(blue) and actin (red). Confocal microscopy, 10x magnification, scale bar = 500 µm. 
Figure 2.13: HUVECs seeded in collagen channel stained for actin and nuclei. Hydrogel formed 
using pre-dissolved collagen solution. Ring-like channel structure is present, but not round. Confocal 




Figure 2.14: HUVECs seeded in GelMa channel adhered throughout the entire channel but jagged 
edges formed when removing the needle appeared to affect cell adhesion and spreading. Cells were 
fixed with paraformaldehyde and labeled for nuclei (blue) and actin (red). (Top) Confocal 
microscopy, 10x magnification, scale bar = 500 µm. (Bottom) Widefield microscopy, 10x 
magnification, scale bar = 500 µm. 
Figure 2.15: HUVECs seeded in collagen/GelMa channel showed fewer jagged edges as compared to 
GelMa channels. Cells were fixed with paraformaldehyde and labeled for nuclei (blue) and actin (red). 
Confocal microscopy, 10x magnification, scale bar = 500 µm. 
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2.3.5 Subjecting Cells to Flow 
Flow experiments were conducted throughout device development, even in cases in 
which the gels did not seem sufficiently stable to withstand flow. Flow experiments (340 
µL/min) using the first collagen device and GFP-mitochondria labeled HUVECs resulted 
in damage to the collagen gel, often detaching the gel from the PDMS device. However, 
even in cases where the gel and channel were forced out of their original positions, cell 
alignment was observed (Figure 2.16). 
Later flow experiments using pre-dissolved collagen hydrogels focused on maintaining 
gel integrity. As such, flow rate was lowered from 340 µL/min as in the previously 
described experiments to 5 µL/min. Although no alignment was observed, channels could 
be continuously perfused for up to 48 hours while still maintaining a lumen-like ring 
structure (Figure 2.17). 
The GelMa devices also withstood extended flow durations, so the flowrate was 
increased to 10 µL/min. Some signs of alignment were observed, but this result was not 
consistently observed (Figure 2.18). HUVECs were also seeded inside collagen/GelMa 
channels and subjected to 10 µL/min flow for 48 hours. The cells remained adhered to the 
channel, and the channel maintained its cylindrical shape. However, no cell alignment was 
observed in the 1:1 collagen/GelMa blend devices, likely due to the lower flow rate (Figure 
2.19). The maximum flowrate achieved while maintaining gel integrity was 20µL/min. 
This corresponds to a shear stress of 0.03 dyne/cm2 which is more representative of a 






Figure 2.16: GFP-mitochondria labeled HUVECs remained in the collagen channel after being 
subjected to flow at 340 µL/min for 1 hour. (Left) The high flow rate disrupted the gel, though some 
parts of the channel could still be imaged. (Right) HUVECs aligned by 1 hour flow. Cells were fixed 
with paraformaldehyde and labeled for nuclei (blue) and actin (red). Confocal microscopy, 10x 
magnification, scale bar = 500 µm. 
Figure 2.17: HUVECs seeded in collagen channel (pre-dissolved collagen) remained adhered to the 
intact channel after 5 µL/min flow for 48 hours. Cells were fixed with paraformaldehyde and labeled 




Figure 2.18: HUVECs seeded in three separate GelMa channels remained adhered and showed some 
sign of cell alignment after 10 µL/min flow for 48 hours. Cells were fixed with paraformaldehyde and 
labeled for nuclei (blue) and actin (red) Confocal microscopy, 10x magnification, scale bar = 100 µm. 
Figure 2.19: HUVECs seeded in three separate collagen/lGelMa channels and subjected to flow at 10 
µL/min for 48 hours remained adhered and all channels maintained their form. Cells were fixed with 
paraformaldehyde and labeled for nuclei (blue) and actin (red). Confocal microscopy, 10x 




The main challenge addressed in this chapter was establishing a protocol to create a 
stable, reliable hydrogel that could withstand channel formation and extended flow 
duration. I first modified the collagen hydrogel gelation protocol to improve the structural 
integrity of the collagen gels, which were initially fragile and easily destroyed during 
channel formation and cell seeding. I then explored using a different hydrogel altogether. 
GelMa hydrogels offered significantly improved gel stability and ease-of-use compared to 
collagen hydrogels. However, channels formed in GelMa hydrogels had jagged edges 
along the channel walls. These edges inhibited unidirectional laminar flow through the 
channel which in turn may have prevented proper cell alignment. It is possible that the rate 
of gelation contributed to the formation of jagged edges. Compared to the slower gelation 
of collagen (hours), GelMa hydrogels are crosslinked as quickly as five minutes. This rapid 
gelation could have increased attachment of the gel to the needle, resulting in jagged edges 
upon needle removal. In future experiemnts, it may be possible to slow the rate of GelMa 
crosslinking to reduce the formation of these jagged edges. Finally, collagen and GelMa 
solutions were mixed to form a hydrogel blend with the gel integrity of GelMa and the 
smooth-wall channels of collagen. 
Other studies have established EC lined hydrogel channels in similar configurations. 
Chrobak et al. developed a collagen channel using a very similar methodology to the artery-
on-a-chip device presented here [74]. In their work, they successfully produced a collagen 
hydrogel channel in a PDMS chip that could be perfused. However, their aim was to form 
a microvascular tube, and as such their channel diameter was at most 150 µm with a 
maximum flowrate of 0.4 ml/hr (6.67 µL/min). The larger scale of our artery-on-a-chip 
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device allows us to study larger vessels and higher flow rates, which are necessary to 
achieve comparable magnitudes of shear stress, but also requires additional mechanical 
support, which we have found in collagen/GelMa blend hydrogels. 
PDMS is a common feature of many organ-on-a-chip devices. However, in most other 
devices, more precise and smaller scale fabrication methods are applied, such as soft 
lithography [75]. In soft lithography, PDMS is cured with a topographical pattern, usually 
using a silicone master produced with photolithography. Different types of soft lithography 
will then use this patterned PDMS in different ways. One approach is to bind the patterned 
PDMS to glass to create microfluidic channels with PDMS walls [76].These types of 
microfluidic devices offer improved precision and consistency between devices. However, 
the size scale for this artery-on-a-chip is significantly larger than those types of devices 
and requires biologically relevant channel walls. While using large molds, as done here, is 
less precise and consistent between devices compared to soft lithography, it is more 
sensible for this device as only a PDMS “shell” is required. While other materials or 
polymers could have fulfilled the same “shell” role as PDMS does in this artery-in-a-chip 
device, the optical transparency of PDMS is necessary to eventually allow direct 
visualization of the vessel contraction. It is possible to create PDMS blends with varying 
mechanical properties. One way to accomplish this would be to vary the ratio of elastomer 
base and curing agent before PDMS curing. However, even with this tuning, the range of 
stiffness of PDMS is not compatible with in vitro SMC contractility [77].  
I now show that collagen/GelMa blends can be used to create stable, smooth-walled 
hydrogel channels. Collagen/GelMa blend hydrogels have previously been investigated by 
Stratesteffen et al. as a novel 3D printable bioink formulation [78]. Stratesteffen et al. used 
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their collagen/GelMa blends such that individual drops could be crosslinked at a time, 
which better lends the material to a 3D printing application. Here, an entire hydrogel 
channel structure was crosslinked and gelled as a single, large construct. An additional 
benefit of incorporating GelMa into the hydrogel channel is that GelMa is significantly 
more patternable compared to collagen, and this gel patterning is integral in our approach 
to aligning muscle cells. GelMa also has natural RGD binding motifs to encourage cell 
adhesion [79].   
These data also show how endothelial cell alignment in the flow direction depends on 
both the shear stress level and the substrate on which the cells adhere. Specifically, it has 
been established that laminar flow that induces physiological shear stress on HUVECs 
aligns them in the flow direction [59]. Flow-based alignment was not observed consistently 
in the different device iterations for various reasons. For initial collagen devices, the gel 
stability was not sufficient for extended flow exposure, even at significantly lower than 
physiological flowrates. GelMa devices suffered from jagged edges that induced disturbed 
instead of laminar flow. Although it was not observed, collagen/GelMa blend devices were 
expected to demonstrate cell alignment. The previously mentioned RGD binding motifs 
present in GelMa provide a clear binding opportunity for β1 integrin, which is a sensor of 
flow direction and essential in EC alignment [80]  It is likely that more physiologically 





In this chapter, I present the process of fabricating the hydrogel channel component of 
the artery-on-a-chip device. Initial devices suffered from a myriad of issues in both the 
PDMS and collagen hydrogel, but after several iterations and adjustments, I determined a 
final PDMS device fabrication method and collagen/GelMa blend hydrogel composition 
that was sufficiently stable to support cell seeding and extended flow exposure. In the next 





3. Topographical Circumferential Alignment of Vascular Smooth Muscle Cells 
3.1 Introduction 
In the vascular system, smooth muscle cells (SMCs) are aligned circumferentially 
about the vessel lumen [81]. This orientation is integral to the function of the muscle cells 
in constricting and dilating the vessel. Recreating this alignment in vitro is therefore a 
necessity in creating an artery-on-a-chip device that can mimic these vasoconstrictive 
functions. 
Kim et al. developed an effective topographical in vitro cell alignment platform that 
serves as a foundation for the work presented here [82]. The platform consists of a flat, 
nano-patterned surface created using poly(urethane acrylate) molding. This platform is 
commercially available as patterned culture dishes through Nanosurface Biomedical. 
However, this nano-patterned surface is only possible in 2D and on rigid substrates. 
Methods have been developed for aligning cells, even specifically SMCs, 
circumferentially about a channel. Choi et al. published a method in which microwrinkles 
were generated along the walls of a PDMS channel, on which SMCs were then seeded [83]. 
The amplitude and frequency of these microwrinkles could be controlled, with more 
intense wrinkles aligning SMCs to a greater degree. While this method is arguably simpler 
and more straightforward than the multi-molding process described in this chapter, PDMS 
is not a physiologically relevant material. In particular, the stiffness of PDMS would make 
it impossible to observe in vitro contractility. 
Since there were no methods to circumferentially pattern SMCs inside a hydrogel 
channel, I developed a new approach that uses 3D printed molds. These molds are 3D 
printed using fused deposition modeling as this process inherently creates ridges on the 
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mold sides that are used as alignment features. I then used this process to pattern flat PDMS 
and GelMa hydrogels, as well as curved surfaces. Finally, I used a water-dissolvable 





3.2.1 Smooth Muscle Cell Culture 
Human aortic smooth muscle cells (SMCs) were cultured in 100mm culture dishes and 
maintained with smooth muscle basal media (SmBM, Lonza, CC-3181) supplemented with 
growth factors (SmGM-2, Lonza, CC-3182). Media was replaced every other day and cells 
were used between passage 4 and 8. For experiments, cells were detached from the culture 
dish and counted as described in Chapter 2. 
3.2.2 SMC Alignment in 2D with Nano-Patterned Culture Dish 
SMCs were seeded into standard 35mm culture dishes (Corning) and commercially 
available 35mm culture dishes with a nano-patterned culture surface (Nanosurface 
Biomedical, ANFS-0001-10) specifically designed to align cells in a single direction. This 
pattern consisted of parallel lines with 800 nm height and 600 nm width. Each line was 
spaced 800 nm apart.  Both types of dishes were coated with rat-tail collagen by preparing 
a 10 µg/mL solution and covering the bottom of the dishes for at least 30 minutes at 37°C. 
Cells were seeded at a density of ~90,000 cells/cm2 and cultured for 24 hours before 
fixation and imaging.  
3.2.3 SMC Alignment on 2D Patterned PDMS 
1 cm cubes were 3D printed with 0.15 mm, 0.25 mm, and 0.35 mm layer-thicknesses 
to act as molds for PDMS patterning. The print parameters were set by the proprietary 
software of the 3D printer (Afinia, H400). Standard polylactic acid (PLA) filament (Afinia, 
25267) was used to print the molds. 
A foundational slab of PDMS was first formed in a 100 mm culture dish as described 
previously. Once fully cured, a wet layer of PDMS was poured onto the slab. The patterning 
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surfaces of the 3D printed molds were also coated with the wet PDMS. The molds were 
inverted onto the wet PDMS on the slab, and the entire culture dish was placed in a 
desiccator to remove air bubbles from the PDMS for 20 to 30 minutes. Any remaining air 
bubbles were manually removed, and the culture dish was placed an oven set to 80°C for 
3 to 24 hours. Once the second layer of PDMS was fully cured, the culture dish was 
removed from the oven. Using a knife and forceps, the 3D printed molds were separated 
from the PDMS, leaving PDMS “wells” patterned with the ridge features from the 3D 
printed molds (Figure 3.1). 
Prior to seeding SMCs, the PDMS wells were UV sterilized for 90 minutes, plasma 
cleaned for 1 minute, and coated with rat-tail collagen (50 µL/mL) for 3 hours at 37°C. 1 
× 106 SMCs were seeded into each PDMS well. After 24 hours, cells were fixed and labeled 
as described below.  
  
Figure 3.1: Molding process with 3D printed molds. (Left) After PDMS curing, the 3D printed molds were 
embedded in the PDMS base. (Right) After the 3D printed molds were removed, the PDMS was patterned with 
alignment ridges. Grid = 10 mm. 
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3.2.4 SMC Alignment on 2D Patterned GelMa 
Patterned PDMS wells were formed as above and left inside the culture dishes. 
Approximately 1 mL of GelMa solution, prepared with 5% gelatin and 0.3% LAP 
photoinitiator, was loaded into each well. The culture dish was closed, sealed with parafilm, 
and UV crosslink for 3 to 5 minutes. Inside a biosafety cabinet, the PDMS was cut and 
peeled away from the patterned GelMa hydrogel. Each patterned GelMa sample was 
transferred into a separate well of a 24-well plate. 1 × 106 SMCs were seeded into each 
well. After 24 hours, cells were fixed and labeled as described below. For imaging, each 
sample was inverted onto a glass coverslip. 
3.2.5 SMC Alignment on Curved Patterned GelMa 
Plastic molds were 3D printed in the desired final geometry of the curved patterned 
GelMa samples. These molds were used to create negative PDMS molds in the same way 
that 2D patterned PDMS samples were created. The negative PDMS molds were cut into 
<1 mm squares such that each mold contained three curved half-channel features. Plastic 
“cages” were printed to keep the GelMa solution in place during crosslinking. A 100 mm 
culture dish was lined with parafilm to prevent GelMa solution leakage out of the cages. 
Each cut negative PDMS mold was placed into a cage, with the pattern face up. 
Approximately 1 mL of GelMa solution with 5% gelatin and 0.3% LAP photoinitiator was 
loaded into each cage. The solution was crosslinked as described previously. Inside a 
biosafety cabinet, each cage was inverted such that the flat face of the negative PDMS 
molds were visible. The negative PDMS molds were carefully peeled away, leaving curved 
patterned GelMa half-channels samples (Figure 3.2). Each sample was transferred into a 
separate well of a 24-well plate and seeded with ~5 × 105 cells as described previously. 
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After 24 hours, cells were fixed and labeled as described below. For imaging, each sample 
was inverted onto a glass coverslip. 
  
Figure 3.2: Curved GelMa patterning process. (Left) 3D printed molds were used to create PDMS negative molds 
of the final GelMa hydrogel shape. PDMS was cut to size. (Center) “Cages” were 3D printed to keep GelMa 
solution in place around PDMS negative molds during crosslinking. (Right) After removal of PDMS negative 
molds, curved, patterned GelMa hydrogel was revealed. 
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3.2.6 Channel Patterning with Dissolvable 3D Printed Molds 
To pattern the inside of a channel, polyvinyl alcohol (PVA) filament was used to print 
molds instead of PLA filament. PVA filament is water-soluble and is traditionally used as 
a support material for 3D printing. 2 mm diameter cylindrical posts were 3D printed at 
0.35, 0.25, and 0.15 mm layer thicknesses. The post base allowed the cylinders to stand 
upright during hydrogel formation. Each post was placed into a well of a 24-well plate and 
~1 mL of wet PDMS was added to each well. After incubation at 80°C overnight, water 
was added to the wells and the well plate was incubated for another overnight period. After 
the PVA posts fully dissolved, the PDMS channels were cut in half to properly visualize 
the channel pattern (Figure 3.3). ~5 x 105 SMCs were seeded onto the PDMS channel 
halves.  
  
Figure 3.3: Channel patterning process in PDMS. (Left) 3D printed PVA posts were placed in a 24-
well plate and surrounded with wet PDMS. (Center) PVA post embedded in cured PDMS. (Right) After 




3.2.7 Cell Fixation and Imaging 
Cells were washed with cold PBS and fixed with 4% paraformaldehyde (PFA, 
Invitrogen, FB002) for 15 minutes on ice. The cells were again washed with PBS for 5 
minutes. 0.1% Triton X-100 (Alfa Aesar, A16046-AP) was used to permeabilize cells for 
5 minutes followed by two additional PBS washes for 5 minutes each. The cells were 
blocked with 1% bovine serum albumin (BSA, Sigma Aldrich, A9418) for 30 minutes and 
then stained with 0.05% Hoechst (Invitrogen, H3570) and 1.25% rhodamine phalloidin 
(Biotium, 00027) to label nuclei and actin, respectively. A confocal laser scanning 
microscope (Nikon, Eclipse Ti2-E) was used to image the cells. Images were obtained at 
10x and 20x magnification over a range of 300-1000 µm in depth. 100 z-stacks were 
acquired to visualize cell alignment along the various patterns and ridge features. 
3.2.8 Alignment Quantification 
Cell alignment was quantified using MatFiber for actin. MatFiber is software 
developed in MATLAB and originally used to quantify collagen fiber orientation in 
myocardial scar tissue in rats after myocardial infarction  [84]. Briefly, the software divides 
an input image into square subregions. Each subregion is assigned a vector based on an 
intensity gradient detection algorithm [85]. The vector angles are calculated to quantify the 
overall orientation of the image. Images are transformed such that expected alignment 




3.3.1 SMC Alignment in 2D with Nano-Patterned Culture Dish 
To demonstrate the feasibility of aligning SMCs in 2D, cells were seeded in 
commercially available culture dishes with a nano-patterned culture surface. Cells were 
also seeded in standard, un-patterned culture dishes as a negative control. As expected, 
when seeded on the un-patterned culture dish, no alignment was observed. In contrast, cells 
seeded on the nano-patterned culture dished showed significant alignment in the direction 
of the patterned lines (Figure 3.4) .   
Figure 3.4: SMCs seeded onto nano-patterned culture surfaces aligned in the pattern direction. (Left) Confocal 
microscopy images of SMCs labeled for nuclei (blue) and actin (red). (Right) Alignment quantification of SMCs 
seeded in an unpatterned culture dish (top) and a nano-patterned culture dish (bottom). Scale bar = 200µm 





































3.3.2 SMC Alignment on 2D Patterned PDMS 
Although SMCs clearly demonstrated alignment due to the topographic cues of the 
nano-patterned culture surface, this rigid 2D surface is far from the final desired artery-on-
a-chip device. To begin working towards the desired circumferential alignment, 
topographical patterned PDMS was explored because of the ability to mold PDMS into 
customizable forms. 
First, 2D topographical patterning of PDMS was accomplished by using 3D printed 
molds in which the ridge dimensions were controlled by adjusting the layer-thickness of 
the 3D printer, which in turn controlled the pattern imparted onto the PDMS surface (Figure 
3.5). Three molds were printed with different layer-thicknesses to determine the effect on 
cell alignment. 
SMCs aligned to a high degree on the patterned PDMS (Figure 3.6), considering that 
the ridge size and spacing was much larger compared to the nano-patterned culture dishes. 
The layer-thickness of each sample did not significantly change the degree of alignment 
(Figure 3.7). These experiments demonstrated that PDMS could be patterned using 3D 




Figure 3.5: Phase contrast images of alignment features in patterned PDMS formed using 3D printed 
PLA molds. Phase contrast microscopy, 5x magnification. 
Figure 3.6: SMCs aligned with the ridges on patterned PDMS. Cells were fixed with paraformaldehyde and 
labeled for nuclei (blue) and actin (red).  Confocal microscopy, 60x magnification, scale bar = 50 µm. 
Figure 3.7: SMC aligned to a similar degree on patterned PDMS of different ridge size.  





















3.3.3 SMC Alignment on 2D Patterned GelMa  
Although the PDMS curing process lends itself to more easily forming 3D structures, 
its mechanical and biological properties do not make it an ideal substrate on which to 
culture SMCs with the intent to induce and observe contractility. GelMa presented an 
appealing combination of 3D structure formation and physiological relevance, both 
biologically and mechanically. The following experiments were designed to determine the 
feasibility of patterning GelMa hydrogels and if possible, if patterned GelMa surfaces 
could align SMCs as in previous experiments. 
Initial attempts at patterning GelMa were carried out nearly identically to the process 
developed to pattern PDMS using 3D printed molds. However, removing the rigid plastic 
molds from the soft GelMa hydrogels was not possible without significantly disrupting the 
hydrogel, damaging any pattern that may have formed. To address this issue, an 
intermediate PDMS molding step was added. The 3D printed molds were used to pattern 
PDMS as before, but these patterned PDMS samples were then used to ultimately pattern 
the GelMa hydrogels. The pliable nature of PDMS allowed the PDMS molds to be cut and 
peeled away from the GelMa hydrogels with minimal damage to the pattern (Figure 3.8). 
When seeding SMCs onto these 2D patterned GelMa samples, less alignment was 
observed compared to SMCs seeded on patterned PDMS samples (Figure 3.9). However, 
alignment was still observed, primarily in the 0.15 mm layer-thickness samples. These 
experiments established that GelMa could feasibly be patterned using 3D printed molds 




Figure 3.8: GelMa hydrogel sample patterned using 0.35mm layer-thickness 3D printed mold. GelMa 
solution was loaded onto patterned PDMS samples and crosslinked in place. Peeling away the PDMS 
revealed the patterned GelMa sample. 
Figure 3.9: SMCs seeded on patterned GelMa samples showed less alignment than cells seeded onto 
PDMS. Cells were fixed with paraformaldehyde and labeled for nuclei (blue) and actin (red).  Yellow 
arrows indicate direction of alignment features. Confocal microscopy, 10x magnification, scale bar = 
























Figure 3.10 SMC showed less overall alignment on GelMa, though the trend of increased alignment 
with decreasing layer thickness remained. 
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3.3.4 SMC Alignment on Curved Patterned GelMa 
The final desired SMC orientation in the artery-on-a-chip device is circumferential 
alignment inside the channel. The next step towards accomplishing this was to adapt the 
GelMa patterning process to create curved patterned surfaces. In these experiments, a half 
channel structure was attempted to determine if curvature would affect the patterning 
process. 
SMCs seeded onto these curved patterned GelMa surfaces again demonstrated some 
alignment (Figure 3.11). Compared to the 2D patterned GelMa samples, the SMC 
alignment on curved patterned GelMa samples was again diminished in alignment and 
consistency as more or less alignment was observed in different areas of the same sample 
(Figure 3.12).  
  
Figure 3.11: SMCs seeded on curved patterned GelMa samples showed some circumferential 
alignment. Curved surfaces were fabricated using a PDMS negative mold. The alignment features 
were inherent to the PDMS mold. SMC were fixed with paraformaldehyde and labeled for nuclei 




Figure 3.12: SMCs seeded on curved patterned GelMa samples patterned with 0.15 mm layer-thickness 
showed some areas with circumferential alignment but also areas without alignment. Curved surfaces 
were fabricated using a PDMS negative mold. The alignment features were inherent to the PDMS mold. 
SMC were fixed with paraformaldehyde and labeled for nuclei (blue) and actin (red). Confocal 
microscopy, 10x magnification, scale bar = 500 µm.  




















Figure 3.13: SMC aligned to on curved GelMa surfaces at 0.25mm and 0.15mm layer thicknesses, 
but not at 0.35mm. 
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3.3.5 Channel Patterning with Dissolvable 3D Printed Molds 
After dissolving the PVA molds, the PDMS channels were clearly patterned by the 
sacrificial molds. However, due to the print quality of the molds, the patterns were not as 
robust as previous samples (Figure 3.14).    
Figure 3.14: PDMS channels patterned with dissolvable PVA mold. 0.35 mm and 0.25 mm layer-
thickness molds printed in non-uniform layers. Phase contrast microscopy, 5x magnification. 




With these experiments, I confirmed that SMCs can be aligned with a simple process 
using 3D printed molds. Of the topographical patterns tested in this chapter, Nanosurface 
Biomedical’s nano-patterned cultured surfaces had the finest alignment features, with the 
smallest feature size being 600 nm. The fine feature size resulted in the clearest cell 
alignment. PDMS offered a more customizable and facile patterning method using 3D 
printed molds. With this 3D printed molding process, I created alignment features in both 
flat and curved PDMS samples. I then established that these patterns were sufficient to 
align SMCs. Although the degree of alignment of cells on PDMS samples was lower than 
that of cells on the nano-patterned culture dish, appreciably alignment was still observed. 
However, PDMS is not a suitable material for the artery-on-a-chip device as it is too stiff 
to allow visible SMC contraction. Therefore, patterning GelMa hydrogels was attempted. 
With a few additional steps to the 3D printed molding process, I created similar alignment 
features on flat and curved GelMa surfaces. Again, the cells alignment on these samples 
decreased compared to cells on PDMS samples, but the GelMa hydrogel composition could 
be further tuned to improve pattern transfer. Finally, I began adapting this 3D printed 
molding process towards the ultimate goal of aligning SMCs circumferentially inside a 
channel. Using 3D printed PVA molds, I was able to pattern a PDMS channel with similar 
alignment features to that of the flat and curved samples. The alignment features were not 
as robust as previous experiments, but this could be remedied with higher quality 3D 
printing. 
To apply this method to the artery-on-a-chip device would first require establishing the 
channel formation process in GelMa. Based on the success of patterning the PDMS channel 
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and of patterning the flat and curved GelMa samples, it appears likely that channel 
patterning in GelMa is possible with this method. Some additional considerations would 
have to be made regarding certain parameters of the 3D printed molding process. The print 
resolution and mold diameter are closely related. Smaller diameter molds require a more 
precise 3D printer for consistency among prints, especially at different layer-thicknesses. 
Although layer-thicknesses did not appear to affect cell alignment, conditions in the artery-
on-a-chip device may cause certain ridge sizes to be more or less effective at aligning cells. 
For instance, the combined effects of layer-thickness and flow would have to be 
investigated. Similarly, the gel composition could affect ridge formation. While GelMa 
could be patterned and demonstrated cell alignment, Chapter 2 experiments indicated that 
GelMa alone was not compatible with the channel formation process. A collagen/GelMa 
blend could be equally patternable, as long as its stiffness is similar to GelMA alone. 
This 3D printed molding process is substantially more cost effective compared to 
techniques that achieve similar results. For example, the nano-patterned culture surfaces 
manufactured by Nanosurface Biomedical cost $160.00 per 24-well plate. 3D printed 
molding does require an initial startup cost to acquire a 3D printer ($500 and up); 
alternatively, most universities have core facilities for 3D printing. In addition, 3D printed 
molds can also be used several times and can be customized to the application. Non-
topographical alignment methods, such as electrical and mechanical stimulation, require 
more complex equipment, limit the conditions in which cells can be cultured, and may 
affect cell physiology in undesired ways that could affect cell function. This simple and 
cost-effective patterning method could make the artery-on-a-chip accessible to many 








In this chapter, I present a novel process of aligning SMCs circumferentially inside a 
channel as they would ultimately be required in the artery-in-a-chip device. Cells were first 
aligned topographically with commercially available rigid pre-patterned surfaces to 
establish a baseline cell alignment. Then, 3D printed molds were used in conjunction with 
PDMS to develop a simple and cost effect method of topographically aligning cells. I 
demonstrated that this method could not only be used to align SMCs in 2D, but also on 
curved surfaces. Although the effectiveness of cell alignment decreased on softer 
hydrogels, alignment was still observed and the patterning process can be tuned as 




4. Conclusions and Future Work 
4.1 Conclusions 
In this thesis, several important steps were taken towards creating a contractile artery-
on-a-chip using human ECs and SMCs. In Aim 1, an optically transparent PDMS-based 
device was used as the artery-on-a-chip foundation. Cells were seeded in a soft hydrogel 
channel that would allow SMC contraction to produce visible changes in diameter, a 
requirement of pressure myography. The hydrogel composition was changed, as early 
compositions were not sufficiently stable to withstand channel formation and extended 
flow. A blend of collagen and GelMa was chosen as the final hydrogel composition. GelMa 
offers a facile crosslinking method, high stability, and strong attachment to the PDMS 
device, in addition to physiologically relevant binding motifs. Using GelMa alone, 
however, resulted in hydrogel channels with jagged edges that hindered cell adherence and 
alignment. Blending GelMa together with collagen lessened the intensity of these jagged 
edges, while still having the benefits of GelMa.  
Another important step towards achieving the contractile artery-on-a-chip was the 
development of a novel method to topographically align SMCs circumferentially. 3D 
printing is a growing technology and, while not as precise, is much more accessible than 
microfabrication methods. 3D printed molds were successfully used to pattern PDMS 
substrates, and SMCs seeded on these substrates aligned with the topographical patterns. 
By simply changing the shape of the 3D printed mold, even curved surfaces were fabricated 
that supported cell alignment features. This was established in both PDMS and GelMa 
hydrogel samples, further speaking to the versatility of this method. Even further still, 
sacrificial molds 3D printed using PVA filament. This water-soluble filament does not 
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significantly complicate or increase the expense of this method, but greatly widens its 
possible uses. In this case, a 3D printed cylindrical sacrificial mold was used to pattern the 
inner walls of a channel with alignment features. 
4.2 Future Work 
The natural progression of the two aims detailed here is to co-culture ECs and SMCs 
within the hydrogel channel. This would begin with first incorporating the hydrogel 
patterning method developed in Aim 2 into the PDMS device. This could be done with 
minor changes to the hydrogel formation process. When SMCs are circumferentially 
aligned inside the channel, the ECs would be seeded in a monolayer on top of the SMCs 
and aligned axially using fluid flow. The next major step would be to validate artery-on-a-
chip vasodilation and vasoconstriction with pressure myography of harvested tissue 
samples. While the artery-on-a-chip device is not expected to respond with the same 
magnitude as a harvested tissue sample, it should at least follow the same type of response 
as a native artery.  
With a validated, contractile artery-on-a-chip device, more comprehensive topics could 
be investigated. Related to atherosclerosis, the device could be modified to create branched 
vessels to observe differences between unidirectional and non-unidirectional flow. The 
time scale for the current device is limited to 48 hours which is signifncantly shorter than 
the time required for atherosclerosis to develop naturally (decades). However, disease 
conditions could be accelerated through the use of NO scavengers to reduce NO 
bioavailability. Additionally, the role of vascular-adjacent tissues could be better studied 
by introducing these cells or tissues to the hydrogel. The effects of perivascular adipose 
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tissue inflammation on vasoconstriction and vasodilation, for example, could be studied in 
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